Severe Vasomotor Symptoms at Menopause Associated With CVD Risk
Among women with menopausal vasomotor symptoms, severity rather than frequency of hot flushes and night sweats is associated with an increased risk for CVD.
Among women with menopausal vasomotor symptoms, severity rather than frequency of hot flushes and night sweats is associated with an increased risk for CVD.
For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years.
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
Lifestyle factors and health status affect the incidence of depression in postmenopausal women, according to cross-sectional study results.
In recently menopausal women using hormone treatment, circulating levels of pituitary-ovarian hormones are associated with changes in white matter hyperintensities.
Exposure to some perfluoroalkyl and polyfluoroalkyl substances may be associated with an earlier onset of natural menopause.
Level of dairy intake does not affect the rate of bone mineral density loss or fracture risk among perimenopausal women.
Gabapentin may be a beneficial therapeutic option for managing vasomotor symptoms in postmenopausal women.
A diet rich in fruits and vegetables may lessen menopause symptoms.
Postmenopausal women with both bilateral salpingo-oophorectomy and a family history of premature myocardial infarction have an increased risk for heart disease mortality, especially those who underwent BSO at an earlier age.